Eryana, I Made
Unknown Affiliation

Published : 2 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 2 Documents
Search

Transient ST Elevation following Anaphylactic Shock: A Case Report of The Potential Kounis Syndrome Aryadi, I Putu Hendri; Eryana, I Made; Sumajaya, I Dewa Gde Dwi
Jurnal Kardiologi Indonesia Vol 46 No 1 (2025): January - March, 2025
Publisher : The Indonesian Heart Association

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.30701/ijc.1292

Abstract

Background: Anaphylactic shock rarely can induce allergic-induced acute coronary syndrome known as Kounis Syndrome. It involves the release of inflammatory cytokines through mast cell activation, which leads to coronary artery vasospasm and ST elevations presentation on electrocardiography (ECG).Case Illustration: A 45-years-old woman with unknown past medical history presented with weakness all over the body, dizziness, pain on left hand and history of fainted, immediately after being stung by small wasps. She was in hypotension with wheezing and weak peripheral pulses. Her laboratory examination displayed leukocytosis, thrombocytosis, high level of blood sugar and triglyceride. Initial twelve-lead ECG demonstrated ST-segment elevation on the inferior leads (II, III, and aVF) and reciprocal ST-depression on the lateral lead. Diagnosis of anaphylactic shock caused by insect bite was made, with a potential of becoming Kounis Syndrome. Treatment for anaphylactic shock was initiated with fluid resuscitation, intramuscular epinephrine, intravenous methylprednisolone and ranitidine. Patient’s complaint vanished and the patient discharged in stable condition two days later.Discussion: Kounis Syndrome consists of three main types, including Type I Kounis Syndrome―manifested as coronary artery vasospasm with/without cardiac biomarker elevation among patient without predisposing factor of coronary artery disease. This type differs with the second and third type, which present plaque erosion or thrombosis, leading to myocardial infarction. The treatment for Type 1 Kounis Syndrome mostly in the form of aborting the anaphylactic reaction only, through medication administration until symptoms resolved. Based on this case, the patient was a non-smoker young Asian woman with a low risk (<1% of 10-years-risk) of fatal cardiovascular disease (CVD) in populations with high CVD risk. Clinically, the patient did not show any vascular thrombotic symptoms. In addition, administration of adrenaline, corticosteroid and antihistamine relieved patient's complaint, thus this case can be hypothesized as a potential Type I Kounis Syndrome. Emergency coronary angiography or echocardiography has to be done to clarify the diagnosis of this allergic-induced acute coronary syndrome.Conclusion: Transient ST elevation could happen in some rare cases following an anaphylactic shock. The swift recognition, accurate diagnosis, and prompt treatment are important for optimal outcomes in the probability of Kounis Syndrome.Keywords: anaphylactic shock, Kounis syndrome, ST elevation
The Role of Folic Acid Supplementation in Reducing Anemia Complications in Patients with Chronic Kidney Disease: A Systematic Analysis of Randomized Controlled Trials Eryana, I Made; Ardanayasa, I Gede Risnawan Suastika
International Journal of Psychology and Health Science Vol. 3 No. 4 (2025): International Journal of Psychology and Health Science (October - December 2025
Publisher : Greenation Publisher & Yayasan Global Research National

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.38035/ijphs.v3i4.1603

Abstract

Chronic Kidney Disease (CKD) is a global health issue with an increasing prevalence, particularly among the elderly population. One of the major complications of CKD is anemia, which negatively impacts patient outcomes, leading to reduced quality of life and increased morbidity and mortality. Folic acid supplementation has been proposed as an effective intervention for managing anemia in CKD patients, but its clinical impact remains controversial. This systematic review aims to evaluate the role of folic acid supplementation in reducing anemia-related complications in CKD patients. Methods: A systematic search was conducted using PubMed, Science Direct, Google Scholar, and the Cochrane Library for randomized controlled trials (RCTs) published between 2014 and 2024. Included studies were those assessing the effects of folic acid supplementation on anemia in CKD patients. The Cochrane Risk of Bias Tool was used to assess the quality of the studies. Data on hemoglobin levels, erythropoiesis-stimulating agent (ESA) use, and other anemia-related outcomes were extracted and synthesized narratively. Results: Five RCTs involving 681 patients were included. Folic acid supplementation consistently improved hemoglobin levels and sideremia in CKD patients across all studies. Three studies reported significant reductions in inflammation markers. One study demonstrated a protective effect of folic acid against contrast-induced nephropathy. Adverse events were rare, with only one study reporting a slight increase in uric acid levels in some patients. Discussion: Folic acid supplementation appears to be an effective and safe intervention for improving anemia in CKD patients, particularly in those with resistance to conventional iron therapies. The benefits include improved hemoglobin levels, reduced inflammation, and potential protection against nephropathy. However, further long-term studies are needed to evaluate the stability of these effects and their impact on patient outcomes.